Effects of galantamine on β-amyloid release and beta-site cleaving enzyme 1 expression in differentiated human neuroblastoma SH-SY5Y cells

被引:30
作者
Li, Qianqian [1 ]
Wu, Donglai [2 ]
Zhang, Liming [1 ]
Zhang, Yan [1 ]
机构
[1] Harbin Med Univ, Affiliated Hosp 1, Dept Neurol, Harbin, Peoples R China
[2] Harbin Vet Res Inst, Harbin, Peoples R China
基金
黑龙江省自然科学基金;
关键词
Galantamine; Amyloid precursor protein; BACE1; beta amyloid; NICOTINIC ACETYLCHOLINE-RECEPTORS; ALPHA-SECRETASE CLEAVAGE; PRECURSOR-PROTEIN; ALZHEIMERS-DISEASE; METABOLISM; KINASE; INVOLVEMENT; PEPTIDE; BRAIN;
D O I
10.1016/j.exger.2010.06.008
中图分类号
R592 [老年病学]; C [社会科学总论];
学科分类号
03 ; 0303 ; 100203 ;
摘要
Galantamine (Gal) is an acetylcholinesterase inhibitor and used to treat the symptoms of Alzheimer s disease (AD) Recent studies show that Gal may affect amyloid precursor protein (APP) metabolism and increase release of secretory APP alpha (sAPP alpha) However the effect of Gal on amyloid-beta peptide (A beta) release and beta-site cleaving enzyme 1 (BACE1) expression is still unknown. Consequently we investigated the effect of Gal on the level of A beta and BACE1 In a differentiated human neuroblastoma cell line (SH-SY5Y) Gal (0 3 mu M) was found to significantly decrease A beta release and BACE1 expression following treatment for 6 12 and 24 h Increasing Gal to 0 9 mu M or 10 pm had no further effect. The effect of Gal (0 3 mu M for 18 h) was maximal on BACE1 expression but not on A beta secretion At higher concentration (0 9 mu M and 10 mu M) Gal had no effect on the level of full-length APP but could still stimulate further decrease in A beta secretion and release of sAPP alpha These observations suggested that 0 3 mu M Gal exerts its effect on A beta production by inhibiting BACE1 expression while 0 9 mu M or 10 mu M Gal mainly reduces A beta production by stimulating the non-amyloidogenic pathway to decrease the amount of APP substrate available for beta-secretase cleavage In addition alpha 7 nicotinic acetylcholine receptor (alpha 7nAChR) and multiple second messengers (including PKC, MEK and p38MAPK) were found to be involved in the regulation of Gal inhibited A beta release and BACE1 expression (C) 2010 Elsevier Inc All rights reserved
引用
收藏
页码:842 / 847
页数:6
相关论文
共 31 条
[1]   MUSCARINIC RECEPTORS IN HUMAN SH-SY5Y NEUROBLASTOMA CELL-LINE - REGULATION BY PHORBOL ESTER AND RETINOIC ACID-INDUCED DIFFERENTIATION [J].
ADEM, A ;
MATTSSON, MEK ;
NORDBERG, A ;
PAHLMAN, S .
DEVELOPMENTAL BRAIN RESEARCH, 1987, 33 (02) :235-242
[2]   Galantamine prevents apoptosis induced by β-amyloid and thapsigargin:: involvement of nicotinic acetylcholine receptors [J].
Arias, E ;
Alés, E ;
Gabilan, NH ;
Cano-Abad, MF ;
Villarroya, M ;
García, AG ;
López, MG .
NEUROPHARMACOLOGY, 2004, 46 (01) :103-114
[3]   Evidence that tumor necrosis factor α converting enzyme is involved in regulated α-secretase cleavage of the Alzheimer amyloid protein precursor [J].
Buxbaum, JD ;
Liu, KN ;
Luo, YX ;
Slack, JL ;
Stocking, KL ;
Peschon, JJ ;
Johnson, RS ;
Castner, BJ ;
Cerretti, DP ;
Black, RA .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (43) :27765-27767
[4]   Cholinergic agonists stimulate secretion of soluble full-length amyloid precursor protein in neuroendocrine cells [J].
Efthimiopoulos, S ;
Vassilacopoulou, D ;
Ripellino, JA ;
Tezapsidis, N ;
Robakis, NK .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1996, 93 (15) :8046-8050
[5]   CLEAVAGE OF AMYLOID-BETA PEPTIDE DURING CONSTITUTIVE PROCESSING OF ITS PRECURSOR [J].
ESCH, FS ;
KEIM, PS ;
BEATTIE, EC ;
BLACHER, RW ;
CULWELL, AR ;
OLTERSDORF, T ;
MCCLURE, D ;
WARD, PJ .
SCIENCE, 1990, 248 (4959) :1122-1124
[6]  
Giacobini E, 2000, J NEURAL TRANSM-SUPP, P231
[7]   NICOTINIC ACETYLCHOLINE-RECEPTORS IN HUMAN NEUROBLASTOMA (SH-SY5Y) CELLS [J].
GOULD, J ;
REEVE, HL ;
VAUGHAN, PFT ;
PEERS, C .
NEUROSCIENCE LETTERS, 1992, 145 (02) :201-204
[8]   AMYLOID BETA-PEPTIDE IS PRODUCED BY CULTURED-CELLS DURING NORMAL METABOLISM [J].
HAASS, C ;
SCHLOSSMACHER, MG ;
HUNG, AY ;
VIGOPELFREY, C ;
MELLON, A ;
OSTASZEWSKI, BL ;
LIEBERBURG, I ;
KOO, EH ;
SCHENK, D ;
TEPLOW, DB ;
SELKOE, DJ .
NATURE, 1992, 359 (6393) :322-325
[9]   REGULATION OF NICOTINIC ACETYLCHOLINE-RECEPTORS ON HUMAN NEUROBLASTOMA-CELLS DURING DIFFERENTIATION [J].
HALVORSEN, SW ;
JIANG, N ;
MALEK, R .
BIOCHEMICAL PHARMACOLOGY, 1995, 50 (10) :1665-1671
[10]   Nicotine reduces Aβ in the brain and cerebral vessels of APPsw mice [J].
Hellström-Lindahl, E ;
Court, J ;
Keverne, J ;
Svedberg, M ;
Lee, M ;
Marutle, A ;
Thomas, A ;
Perry, E ;
Bednar, I ;
Nordberg, A .
EUROPEAN JOURNAL OF NEUROSCIENCE, 2004, 19 (10) :2703-2710